Serum concentration of the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful indicator of decline and recovery of bone mineral density in lumbar spine: Analysis in Japanese postmenopausal women with or without hormone replacement

Endocrine Journal

Volumn 45, Issue 1, 1998, Pages 45-51

  Yasumizu, Takehiko ^a   Hoshi, Kazuhiko ^a   Iijima, Sumio ^a   Asaka, Akio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Bone mineral density; Carboxyterminal telopeptide of type I collagen (ICTP); Carboxyterminal telopeptide of type I procollagen (PICP); Lumbar spine; Postmenopausal woman

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; CONJUGATED ESTROGEN; HYSRON; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; COLLAGEN METABOLISM; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; JAPAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL;

EID: 0031924775     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.45     Document Type: Article

References (25)

1. Rizzouli R, Slosman D, Bonjour JP (1995) The role of dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis. Am J Med 98 (suppl 2A): 33-36.
2. Koizumi K, Uchiyama G, Araki T, Hihara T, Ogata H, Monzawa S (1990) Fundamental evaluation of bone densitometry using dual energy X-ray absorptiometry (DEXA). Nippon Acta Radiologica 50: 123-129 (In Japanese).
3. Meikko J, Niemi S, Risteli J (1990) Radioimmunoassay of the carboxy-terminal propeptide of human type I procollagen. Clin Chem 36: 1328-1332.
4. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyl terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39: 635-640.
5. Deftos LJ (1991) Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 37: 1143-1148.
6. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J (1993) Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 8: 127-132.
7. Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF (1994) Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: Relation to calcium kinetics. Bone Miner 24: 81-94.
8. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG (1994) The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79: 366-371.
9. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79: 1693-1700.
10. Kushida K, Takahashi M, Kawana K, Inoue T (1995) Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 80: 2447-2450.
11. Lotz J, Steeger D, Hafner G, Ehenthal W, Heine J, Prellwitz W (1995) Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry. Calcif Tissue Int 57: 253-257.
12. Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C (1994) The carboxyl-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: The effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int 54: 30-33.
13. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM (1994) Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 40: 358-363.
14. Suzuki A, Ohara A, Yasui T, Mori K, Mori T (1984) Fundamental and clinical investigation of the estradiol direct radioimmunoassay kit. Clinical Endocrinol 33: 627-632 (In Japanese).
15. Johansen JS, Riis BJ, Delmas PD, Christiansen C (1988) Plasma BGP: An indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Cin Invest 18: 191-195.
16. Slemenda C, Hui SL, Longscope C, Johnston CC (1987) Sex steroid and bone mass. A study of changes about the time of menopause. J Clin Invest 80: 1261-1269.
17. Yasumizu T, Kato J (1996) Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr J 43: 191-195.
18. Riggs BL, Jowsey J, Goldschmith RS, Kelly PJ, Hoffman DL, Arnaud CD (1972) Short and long term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest 51: 1659-1662.
19. Smedsrød B, Melkko J, Risteli L, Risteri J (1990) Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 271: 345-350.
20. Gundberg CM, Hauschka PV, Lian JB, Gallop PM (1972) Osteocalcin: Isolation, characterization and detection. Methods Enzymol 107: 516-521.
21. Yasumizu T, Ogawa K, Ka to J (1996) Comparison of clinicopathological characteristics in premenopausal and postmenopausal endometrial carcinomas: Analysis of endocrinologically evaluated cases. Jpn J Clin Oncol 26: 152-156.
22. Norimatsu K, Mori H, Uesato T, Yoshikawa T, Katsuyama N (1989) Bone mineral density of the spine and proximal femur in normal and osteoporotic subjects in Japan. Bone Mineral 5: 213-222.
23. Mazess RB, Barden HS, Ettinger M, Johnson C, Dawson-Hughes B, Powell M (1987) Spine and femur density using dual photon absorptiometry in US white women. Bone Mineral 2: 213-219.
24. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72: 367-373.
25. Garnero P, Gineyts E, Riou JP, Delmas PD (1994) Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79: 780-785.